title: Comparison of the efficacy and safety of Sandoz low molecular weight heparin and unfractionated heparin: interim analysis of a multicenter trial.
authors.affiliation: Sandoz AG, Medical Department, Nürnberg, Germany.
authors.forename: H
authors.initials: H
authors.lastname: Wolf
authors.forename: A
authors.initials: A
authors.lastname: Encke
authors.forename: S
authors.initials: S
authors.lastname: Haas
authors.forename: D
authors.initials: D
authors.lastname: Welzel
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000758:Anesthesia; D005260:Female; D006493:Heparin / Q000009:adverse effects*; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000517:prevention & control*; D011446:Prospective Studies; D011655:Pulmonary Embolism / Q000517:prevention & control*
chemical_list: D006495:Heparin, Low-Molecular-Weight; D006493:Heparin